Latest News about MRNA
Recent news which mentions MRNA
10 Health Care Stocks Whale Activity In Today's Session
February 01, 2022
From Benzinga
Could This Be A Potential New Weapon In The Fight Against COVID-19?
February 01, 2022
From Benzinga
After Dropping 40%, Is Novavax a Buy?
February 01, 2022
From Motley Fool
Monday's Melt-Up Leaves the Market Muddled
January 31, 2022
From Motley Fool
Value Seekers Ought To Have Moderna on Their Radar Now
January 31, 2022
From InvestorPlace
Novavax: The Fall of a Covid-19 Vaccine Star
January 31, 2022
From InvestorPlace
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
From Benzinga
From Motley Fool
Market corrections are good buying opportunities, says Goldman Sachs — but only when this happens
January 31, 2022
From MarketWatch
Could Moderna Beat Novavax to Market With a COVID-Flu Vaccine?
January 30, 2022
From Motley Fool
From Motley Fool
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
From Motley Fool
What's Next For Novavax Stock?
January 29, 2022
From Motley Fool
3 Things About BioNTech That Smart Investors Know
January 29, 2022
From Motley Fool
Why Novavax Stock Surged 14% on Friday
January 28, 2022
From Motley Fool
Novavax Could Be the Biggest Bargain in the Market Right Now
January 28, 2022
From InvestorPlace
From Motley Fool
Why Novavax Stock Is Sinking Again This Week
January 27, 2022
From Motley Fool
Fractional Investment Opportunity In Beachfront Multifamily Property: Last Call To Invest
January 27, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
From Benzinga
IAVI, Moderna Kickstart HIV Vaccine Antigens Trial Delivered Through mRNA Technology
January 27, 2022
Tickers
MRNA
From Benzinga
U.S. daily COVID case tally now falling and hospitalizations seem to be peaking, as Moderna launches trial of omicron-specific booster
January 27, 2022
From MarketWatch
From MarketWatch
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
January 27, 2022
From Benzinga
1 Top Biotech Stock Ready for a Bull Run
January 27, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.